FIELD: medicine; pharmaceuticals.
SUBSTANCE: disclosed are pharmaceutical compositions containing a compound of formula (I), as defined herein, and an amount of an alkaline effervescent agent sufficient to provide satisfactory in vitro dissolution; and additionally containing one or more pharmaceutically acceptable ingredients; and methods for their preparation.
EFFECT: formulations are useful for treating of cancer.
6 cl, 11 ex, 22 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DOSAGE FORMS CONTAINING TENELIGLIPTIN OXALATE SALTS AND SOLVATES THEREOF | 2018 |
|
RU2742418C1 |
| PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION OF ENTACAPONE OR ITS SALTS | 2009 |
|
RU2540465C2 |
| MEDICAL USE OF PYRROLOPYRIMIDINE COMPOUND AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND | 2019 |
|
RU2810112C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| CRYSTALLINE FORMS AND METHODS FOR OBTAINING LENVATINIB BESYLATE | 2019 |
|
RU2801812C2 |
| STABLE ATORVASTATIN COMPOSITIONS OBTAINED BY HUMID GRANULATION | 2004 |
|
RU2332211C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING 3-(2, 2-DIFLUOROBENZO[d][1, 3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID, AND ADMINISTRATION THEREOF | 2011 |
|
RU2592368C2 |
| NOVEL COMPOSITIONS CONTAINING QUINOLINE COMPOUNDS | 2005 |
|
RU2339622C2 |
| SODIUM IBUPROFEN TABLETS AND METHODS FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM IBUPROFEN | 2010 |
|
RU2715680C2 |
| PHARMACEUTICAL COMPOSITIONS OF MONTELUCAST AND LEVOCETIRISINE | 2013 |
|
RU2677649C2 |
